As was already the case before the Covid-19 pandemic, dementia was the third-most common cause at 8.8%, the Federal Statistical Office (FSO) said on Monday. Respiratory diseases (6.1%) and Covid itself (5.5%) were next-most lethal.
Last year, the standardised mortality rate was 504 per 100,000 for men – with an average age at death of 77 – and 352 per 100,000 for women, with an average age of 83.
Cardiovascular diseases accounted for 9,512 deaths (26.1%) among men and 10,951 (28.8%) among women. The standardised rate increased by 0.5% for the former (+398 deaths) and by 1% for the latter (+420 deaths). The average age of men who died from such a disease was 81.4, compared to 87.4 for women.
In 2022, 17,220 people died of cancer. The disease proved fatal for 9,310 men, with an average age of 75, and 7,910 women, also with an average age of 75. Compared to 2021, the standardised rate for men decreased by 2.3%, but with 45 more deaths. For women, the rate increased or 2.1% (+295 deaths). The most deadly form was lung cancer.
Last year, 4,114 people died as a result of Covid-19, with an average age of 82 for men and 85 for women. Compared to the previous year, the standardised rate decreased by 34.1% (-949 deaths) for the former and by 33.6% (-894) for the latter. Six deaths were also indicated as being due to side effects of the coronavirus vaccination.
Road traffic accidents caused 233 deaths, 173 of whom were men with an average age of 54, and 60 women with an average age of 53. Here, the standardised mortality rate for men (three per 100,000) was three times higher than for women (one per 100,000). For the latter there was a 71% increase (+17 deaths) and for men a 13% increase (also +17).
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Sylvain Saudan, ‘skier of the impossible’, dies aged 87
This content was published on
The Swiss father of extreme skiing pioneered descents from the Alps to the Himalayas – and became the sport’s first star.
Hayek family buys additional Swatch shares for nearly CHF11 million
This content was published on
Following the acquisition of registered shares worth over CHF20.6 million on Monday, the Hayek family made another purchase on Tuesday.
Suicide capsule to be used in Switzerland this year, says euthanasia organisation
This content was published on
The organisation “The Last Resort” has confirmed that the suicide capsule Sarco is to be used in Switzerland. This should happen this year, it said.
Ukrainian children flown to Switzerland for cancer treatment
This content was published on
The Swiss air rescue service Rega flew two Ukrainian children with cancer to Switzerland from a hospital in Kyiv hit by Russian missiles.
Swiss Solidarity raises over CHF10 million for victims of extreme weather
This content was published on
The money raised will be used to help those affected by the recent storms and flooding in the cantons of Ticino, Graubünden, and Valais.
Swiss giant Roche given green light for lung cancer drug in Canada
This content was published on
According to a recent study, Roche’s Alecensaro reduced the risk of recurrence or death by 76% compared to chemotherapy alone.
Swiss luxury watch market hit hard by China-led slump
This content was published on
Sales of Swiss-made luxury watches are in sharp retreat as nervous consumers reconsider splashing out on expensive timepieces and demand slumps.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.